Pricing Log in Create free account
Saturday 17 October 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Quest Diagnostics Incorporated (DGX) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Quest Diagnostics Incorporated (DGX) trades at a price to free cash flow of 19.3×. Over the past ten years it has ranged from 7.6× (June 2021) to 26.5× (December 2023); the current reading is higher than 92% of that period. That is below the Diagnostics & Research industry median of 35.8× and in line with the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 14.2× (23.06%)
FY2024 18.4× 0.92%
FY2023 18.3× 32.75%
FY2022 13.8× 16.36%
FY2021 11.8× 17.45%
FY2020 10.1× (40.72%)
FY2019 17.0× 22.46%
FY2018 13.9× (5.57%)
FY2017 14.7× (6.66%)
FY2016 15.7× (14.34%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 17.4× 7.27%
Mar 2026 16.3× 14.71%
Dec 2025 14.2× (7.50%)
Sep 2025 15.3× (6.78%)
42 more quarters

Against its own ten years

Low 7.6× High 26.5×
Ten-year median 16.2×
Current reading's percentile 92

Price to free cash flow against peers

Company Price to free cash flow
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated 19.3×
MEDP Medpace Holdings, Inc. compare 24.7×
LH Labcorp Holdings Inc. compare 25.2×
RVTY Revvity Inc. compare 30.1×
IDXX IDEXX Laboratories, Inc. compare 35.8×
MTD Mettler-Toledo International, Inc. compare 37.8×
ILMN Illumina, Inc. compare 43.2×
WAT Waters Corporation compare 117×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on DGX